Warfarin Adherence and Its Associated Factors in Thai Older Adults with Atrial Fibrillation
- PMID: 39295959
- PMCID: PMC11409932
- DOI: 10.2147/JMDH.S472597
Warfarin Adherence and Its Associated Factors in Thai Older Adults with Atrial Fibrillation
Abstract
Introduction: Older people mostly found unable to adhere with warfarin treatment guidelines. The health service system is challenged in order to improve medication adherence in older population under limited health resources. The purpose of this study was to explore health systems factors on warfarin adherence in older population, particularly in resources constraint setting.
Methods: This study was a cross-sectional predictive study that enrolled older people who experienced atrial fibrillation (AF) and treated by warfarin, aged 60 years and over, and followed up at the warfarin clinic.
Results: A total of 197 participants with the mean age of 72.03 years (SD = 8.84) was recruited. Almost of them (85.8%) reported adhered to warfarin prescription. More than a half (60.5%) were able to report their targeted INR. Participants who stayed with the family had 5.54 times (95% CI 1.79-19.33), took regular daily dose warfarin had 5.07 times (95% CI 1.05-24.49), perceived targeted INR had 2.94 times (95% CI 1.04-8.29), and received family support had 1.33 times (95% CI 1.11-1.60) increased odds of warfarin adherence than those who did not. Participants who perceived a barrier to taking medication had 0.93 times decreased odds of warfarin adherence than those who did not (95% CI 0.86-0.99).
Conclusion: Healthcare system should encourage family to support the older population with AF in order to increase warfarin adherence. Future research should develop intervention combining family support to promote warfarin adherence.
Keywords: INR; adherence; atrial fibrillation; older population; warfarin.
© 2024 Poungkaew et al.
Conflict of interest statement
The authors report no conflicts of interest in this work.
Similar articles
-
Anticoagulation adherence and its associated factors in patients with atrial fibrillation: a cross-sectional study.BMJ Open. 2019 Sep 3;9(9):e029974. doi: 10.1136/bmjopen-2019-029974. BMJ Open. 2019. PMID: 31481562 Free PMC article.
-
Association Between Warfarin Control Metrics and Atrial Fibrillation Outcomes in the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation.JAMA Cardiol. 2019 Aug 1;4(8):756-764. doi: 10.1001/jamacardio.2019.1960. JAMA Cardiol. 2019. PMID: 31268487 Free PMC article.
-
Warfarin Management and Outcomes in Patients with Nonvalvular Atrial Fibrillation Within an Integrated Health Care System.J Manag Care Spec Pharm. 2017 Jun;23(6):700-712. doi: 10.18553/jmcp.2017.23.6.700. J Manag Care Spec Pharm. 2017. PMID: 28530526 Free PMC article.
-
Warfarin adherence and anticoagulation control in atrial fibrillation patients: a systematic review.Eur Rev Med Pharmacol Sci. 2021 Dec;25(24):7926-7933. doi: 10.26355/eurrev_202112_27642. Eur Rev Med Pharmacol Sci. 2021. PMID: 34982455
-
Interventions for improving medication-taking ability and adherence in older adults prescribed multiple medications.Cochrane Database Syst Rev. 2020 May 8;5(5):CD012419. doi: 10.1002/14651858.CD012419.pub2. Cochrane Database Syst Rev. 2020. PMID: 32383493 Free PMC article.
Cited by
-
The burden of atrial fibrillation and unmet needs of its management in Southeast Asia and South Asia.Lancet Reg Health Southeast Asia. 2025 Feb 21;34:100549. doi: 10.1016/j.lansea.2025.100549. eCollection 2025 Mar. Lancet Reg Health Southeast Asia. 2025. PMID: 40070553 Free PMC article. No abstract available.
References
-
- January CT, Wann LS, Alpert JS, et al. AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American heart association task force on practice guidelines and the heart rhythm society. Circulation. 2014;130(23):2071–2104. doi:10.1161/CIR.0000000000000040 - DOI - PubMed
LinkOut - more resources
Full Text Sources